+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Bioprocess Validation Market by Test Type (Compatibility Testing Services, Extractables or Leachables Testing Services, Integrity Testing Services), Process Component (Bioreactors, Filter Elements, Freezing & Thawing Process Bags), End User - Forecast 2024-2030- Product Image
Global Bioprocess Validation Market by Test Type (Compatibility Testing Services, Extractables or Leachables Testing Services, Integrity Testing Services), Process Component (Bioreactors, Filter Elements, Freezing & Thawing Process Bags), End User - Forecast 2024-2030- Product Image
Sale

Global Bioprocess Validation Market by Test Type (Compatibility Testing Services, Extractables or Leachables Testing Services, Integrity Testing Services), Process Component (Bioreactors, Filter Elements, Freezing & Thawing Process Bags), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829925
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioprocess Validation Market size was estimated at USD 395.47 million in 2023, USD 453.57 million in 2024, and is expected to grow at a CAGR of 14.78% to reach USD 1,038.34 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Validation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bioprocess Validation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bioprocess Validation Market, highlighting leading vendors and their innovative profiles. These include Almac Group, BiOZEEN, Eurofins Scientific SE, Hangzhou Anow Microfiltration Co., Ltd., Hangzhou Cobetter Filtration Equipment Co., Ltd., Intertek Group PLC, Meissner Filtration Products, Inc., Merck KGaA, Nelson Laboratories, LLC by Sotera Health company, Pall Corporation, Porvair PLC, Sartorius AG, SGS S.A., Thermo Fisher Scientific, Inc., and West Pharmaceutical Services, Inc.

Market Segmentation & Coverage

This research report categorizes the Bioprocess Validation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test Type
    • Compatibility Testing Services
    • Extractables or Leachables Testing Services
    • Integrity Testing Services
    • Microbiological Testing Services
  • Process Component
    • Bioreactors
    • Filter Elements
    • Freezing & Thawing Process Bags
    • Media Containers & Bags
    • Mixing Systems
    • Transfer Systems
  • End User
    • Biotechnology Companies
    • Contract Development & Manufacturing Organizations
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Bioprocess Validation Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bioprocess Validation Market?
  3. What are the technology trends and regulatory frameworks in the Bioprocess Validation Market?
  4. What is the market share of the leading vendors in the Bioprocess Validation Market?
  5. Which modes and strategic moves are suitable for entering the Bioprocess Validation Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bioprocess Validation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Precise safety and quality regulations
5.1.1.2. Rising demand for biopharmaceuticals
5.1.1.3. Growing need for outsourcing bioprocess validation
5.1.2. Restraints
5.1.2.1. High cost of bioprocess validation
5.1.3. Opportunities
5.1.3.1. Development of new validation methods for next-generation bioproducts
5.1.3.2. Emergence of cell & gene therapy in the healthcare sector
5.1.4. Challenges
5.1.4.1. Functional issues with validation processes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Bioprocess Validation Market, by Test Type
6.1. Introduction
6.2. Compatibility Testing Services
6.3. Extractables or Leachables Testing Services
6.4. Integrity Testing Services
6.5. Microbiological Testing Services
7. Bioprocess Validation Market, by Process Component
7.1. Introduction
7.2. Bioreactors
7.3. Filter Elements
7.4. Freezing & Thawing Process Bags
7.5. Media Containers & Bags
7.6. Mixing Systems
7.7. Transfer Systems
8. Bioprocess Validation Market, by End User
8.1. Introduction
8.2. Biotechnology Companies
8.3. Contract Development & Manufacturing Organizations
8.4. Pharmaceutical Companies
9. Americas Bioprocess Validation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bioprocess Validation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bioprocess Validation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Almac Group
13.1.2. BiOZEEN
13.1.3. Eurofins Scientific SE
13.1.4. Hangzhou Anow Microfiltration Co., Ltd.
13.1.5. Hangzhou Cobetter Filtration Equipment Co., Ltd.
13.1.6. Intertek Group PLC
13.1.7. Meissner Filtration Products, Inc.
13.1.8. Merck KGaA
13.1.9. Nelson Laboratories, LLC by Sotera Health company
13.1.10. Pall Corporation
13.1.11. Porvair PLC
13.1.12. Sartorius AG
13.1.13. SGS S.A.
13.1.14. Thermo Fisher Scientific, Inc.
13.1.15. West Pharmaceutical Services, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BIOPROCESS VALIDATION MARKET RESEARCH PROCESS
FIGURE 2. BIOPROCESS VALIDATION MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOPROCESS VALIDATION MARKET DYNAMICS
FIGURE 7. BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 8. BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2023 VS 2030 (%)
FIGURE 10. BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BIOPROCESS VALIDATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES OR LEACHABLES TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 11. BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING & THAWING PROCESS BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS & BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 33. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 36. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 50. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 53. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 59. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 77. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 90. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 96. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 117. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. BIOPROCESS VALIDATION MARKET LICENSE & PRICING

Companies Mentioned

  • Almac Group
  • BiOZEEN
  • Eurofins Scientific SE
  • Hangzhou Anow Microfiltration Co., Ltd.
  • Hangzhou Cobetter Filtration Equipment Co., Ltd.
  • Intertek Group PLC
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • Nelson Laboratories, LLC by Sotera Health company
  • Pall Corporation
  • Porvair PLC
  • Sartorius AG
  • SGS S.A.
  • Thermo Fisher Scientific, Inc.
  • West Pharmaceutical Services, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 453.57 Million
Forecasted Market Value ( USD ) by 2030 $ 1038.34 Million
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Bioprocess Validation Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Bioprocess Validation Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Bioprocess Validation - Global Strategic Business Report - Product Image

Bioprocess Validation - Global Strategic Business Report

  • Report
  • 385 Pages
  • Global
From
Bioprocess Validation Market Report 2023-2033 - Product Image

Bioprocess Validation Market Report 2023-2033

  • Report
  • 315 Pages
  • Global
From
Global Bioprocess Validation Market: Focus on End Users, Product, Test Type, Region and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Bioprocess Validation Market: Focus on End Users, Product, Test Type, Region and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 147 Pages
  • Global
From
Bioprocess Validation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Bioprocess Validation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 139 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.